Features & Compatibility
Retatrutide, also known as LY3437943, is an investigational peptide designed to act on three metabolic hormone receptors: GIP, GLP-1, and glucagon receptors. Its multi-receptor mechanism makes it a compound of interest in research related to metabolic signaling, glucose and lipid metabolism, energy balance, and body-weight regulation.
With its triple-agonist profile, Retatrutide provides researchers with a valuable reference compound for exploring interactions between multiple metabolic pathways. It is available in several strengths to accommodate different laboratory and analytical requirements.
Available Format: 10 vials per set, with multiple strength options.
For laboratory research use only. Not intended for human consumption, diagnosis, treatment, or therapeutic use.
Customer Reviews
Related Products
Eloralintide
Eloralintide, formerly known as LY3841136, is an investigational, long-acting and selective amylin receptor agonist. It is designed to mimic amylin,
Ipamorelin
Ipamorelin is a synthetic peptide and selective growth hormone secretagogue receptor (GHS-R) agonist. It is studied for its ability to
Klow80
Klow is a four-component research peptide blend combining GHK-Cu, TB-500, BPC-157 and KPV. The formula is designed for laboratory research
NAD+
NAD+ (Nicotinamide Adenine Dinucleotide) is an essential coenzyme naturally present in living cells. It plays a central role in cellular
Semaglutide
Semaglutide is a GLP-1 analogue and GLP-1 receptor agonist that selectively binds to and activates GLP-1 receptors. It is widely
TB500(Thymosin B4 Acetate)
TB-500 is a synthetic research peptide related to Thymosin Beta-4, a naturally occurring actin-binding peptide involved in cellular organization and

Reviews
There are no reviews yet.